𝛼SK or Search

ENTITY

Cohance Lifesciences (COHANCE IN)

33

Analysis

Health Care • India

Cohance Lifesciences operates as a global Contract Development and Manufacturing Organization (CDMO) and API platform, providing services for small molecule APIs, advanced intermediates, and finished dosage forms. The company offers integrated solutions from early-stage development to commercial-scale manufacturing for pharmaceutical, biotechnology, and chemical companies. Cohance Lifesciences is headquartered in Hyderabad, India, and was founded in 2018.

more

Refresh

Exchange Announcement • 18 Jul 2024 13:22

Suven Pharmaceuticals Ltd - 543064 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Exchange Announcement • 17 Jul 2024 19:33

Suven Pharmaceuticals Ltd - 543064 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Exchange Announcement • 16 Jul 2024 23:51

Suven Pharmaceuticals Ltd - 543064 - Business Responsibility and Sustainability Reporting (BRSR)

Exchange Announcement • 16 Jul 2024 23:48

Suven Pharmaceuticals Ltd - 543064 - Reg. 34 (1) Annual Report.

Exchange Announcement • 16 Jul 2024 23:42

Suven Pharmaceuticals Ltd - 543064 - Notice Of The Sixth Annual General Meeting (AGM) And Annual Report 2023-24

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x